Voyager Therapeutics, Inc. (VYGR) Ownership
VYGR ownership summary
as of October 18, 2026- Institutions
- 57.9% of shares outstanding
- Insiders
- 14.84% of shares outstanding
- Shares outstanding
- 61.6M
- Float
- 44.5M shares available to trade
- Short interest
- 7.55% 4.0M shares short
- Days to cover
- 7.57 short interest up 8.7% vs prior month
- Institutions 57.90%
- Insiders 14.84%
- Other investors 27.26%
VYGR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.39% | 5.2M | $9.8M | −396,318 (−7.1%) | June 30, 2026 |
| 2 | Millennium Management LLC | 7.21% | 4.4M | $8.4M | +1.0M (+29.6%) | June 30, 2026 |
| 3 | Armistice Capital, LLC | 5.58% | 3.4M | $6.5M | −64,000 (−1.8%) | June 30, 2026 |
| 4 | Vestal Point Capital LP | 4.26% | 2.6M | $5.0M | −377,936 (−12.6%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 3.81% | 2.3M | $4.5M | +62,421 (+2.7%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 2.16% | 1.3M | $2.5M | +280,514 (+26.7%) | June 30, 2026 |
| 7 | Opaleye Management Inc | 1.92% | 1.2M | $2.3M | +35,000 (+3.0%) | June 30, 2026 |
| 8 | State Street Corp | 1.75% | 1.1M | $2.0M | +128,196 (+13.5%) | June 30, 2026 |
| 9 | Two Sigma Investments LLC | 1.54% | 949K | $1.8M | +332,857 (+54.1%) | June 30, 2026 |
| 10 | Dimensional Fund Advisors, Inc. | 1.36% | 838K | $1.6M | −37,384 (−4.3%) | June 30, 2026 |
| 11 | Vanguard Portfolio Management, LLC | 1.31% | 810K | $1.5M | +84,322 (+11.6%) | June 30, 2026 |
| 12 | Citadel Advisors Llc | 1.27% | 784K | $1.5M | +419,403 (+115.0%) | June 30, 2026 |
| 13 | Morgan Stanley - Brokerage Accounts | 1.13% | 697K | $1.3M | +15,623 (+2.3%) | June 30, 2026 |
| 14 | Erste Asset Management GmbH | 1.04% | 639K | $1.2M | −456,241 (−41.7%) | June 30, 2026 |
| 15 | Renaissance Technologies Corp | 0.80% | 495K | $940,948 | −82,788 (−14.3%) | June 30, 2026 |
| 16 | Acadian Asset Management LLC | 0.70% | 429K | $814,473 | +179,799 (+72.2%) | June 30, 2026 |
| 17 | Sphera Funds Management Ltd. | 0.69% | 428K | $812,353 | −42,207 (−9.0%) | June 30, 2026 |
| 18 | Diadema Partners LP | 0.67% | 414K | $785,920 | −10,000 (−2.4%) | June 30, 2026 |
| 19 | Northern Trust Corp | 0.67% | 412K | $782,426 | +26,960 (+7.0%) | June 30, 2026 |
| 20 | AQR Capital Management LLC | 0.58% | 356K | $676,607 | +123,428 (+53.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 2.7M shares and 8 cut 1.5M.
VYGR top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.71% | 1.7M | $3.2M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.24% | 1.4M | $2.6M | −15,936 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 0.93% | 570K | $1.1M | −703 (−0.1%) | July 31, 2026 |
| 4 | iShares Russell 2000 Value ETF | 0.80% | 492K | $935,245 | +746 (+0.2%) | September 30, 2026 |
| 5 | Vanguard Explorer Inv | 0.74% | 457K | $868,420 | — | June 30, 2026 |
| 6 | iShares Biotechnology ETF | 0.62% | 385K | $731,130 | −2,912 (−0.8%) | September 30, 2026 |
| 7 | Vanguard Russell 2000 ETF | 0.49% | 304K | $578,151 | +1,734 (+0.6%) | September 30, 2026 |
| 8 | BSF Systematic US Eq Abs Ret A2 USD | 0.46% | 283K | $537,453 | −102,723 (−26.6%) | December 31, 2025 |
| 9 | Fidelity Extended Market Index | 0.45% | 279K | $529,473 | −1,498 (−0.5%) | August 31, 2026 |
| 10 | Galileo - Biotech Innovation Fund S USD | 0.42% | 261K | $495,102 | — | March 31, 2026 |
| 11 | JPM Thmtcs Gentc Thrps C2 dist USD | 0.39% | 242K | $460,220 | −2,942 (−1.2%) | September 30, 2026 |
| 12 | DFA US Small Cap I | 0.31% | 190K | $360,578 | −31,042 (−14.1%) | August 31, 2026 |
| 13 | iShares Micro-Cap ETF | 0.27% | 166K | $314,898 | −1,143 (−0.7%) | September 30, 2026 |
| 14 | Fidelity Enhanced Small Cap Core ETF | 0.27% | 165K | $313,285 | +345 (+0.2%) | September 30, 2026 |
| 15 | Bridge Builder Tax Managed Sm/Md Cp | 0.25% | 157K | $298,463 | — | September 30, 2026 |
| 16 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.22% | 133K | $252,480 | −9,268 (−6.5%) | September 30, 2026 |
| 17 | Schwab Small Cap Index | 0.21% | 128K | $244,057 | — | August 31, 2026 |
| 18 | Avantis US Small Cap Equity ETF | 0.19% | 120K | $227,388 | — | September 30, 2026 |
| 19 | Mackenzie GQE US Small Cap F8 | 0.18% | 111K | $210,906 | +111,003 (0.0%) | July 31, 2026 |
| 20 | iShares Russell 2000 Small-Cap Idx Instl | 0.18% | 108K | $206,021 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VYGR insider transactions
latest 9| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Alfred Sandrock | Sell | $3.87 | 11,511 | $44,548 |
| 2026-02-24 | Alfred Sandrock | Sell | $3.79 | 14,197 | $53,807 |
| 2026-02-24 | Nathan D Jorgensen | Sell | $3.77 | 4,668 | $17,598 |
| 2026-02-24 | Robin Swartz | Sell | $3.77 | 6,458 | $24,347 |
| 2026-02-24 | Todd Alfred Carter | Sell | $3.76 | 4,174 | $15,694 |
| 2026-02-10 | Alfred Sandrock | Sell | $3.78 | 12,192 | $46,086 |
| 2026-02-10 | Robin Swartz | Sell | $3.85 | 4,569 | $17,591 |
| 2026-02-10 | Todd Alfred Carter | Sell | $3.85 | 3,525 | $13,571 |
| 2025-10-03 | Nathan D Jorgensen | Sell | $4.78 | 7,666 | $36,643 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VYGR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VYGR
Institutional investors own 57.9% of Voyager Therapeutics's shares and insiders 14.84%. The largest holder is BlackRock Inc with 8.39% of the shares (5.2M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 7.55% of the float, or 7.57 days of average trading volume. The share count rose 1,430.5% since 2014.
Related: VYGR analyst forecast, VYGR key metrics. See the VYGR stock overview for the latest quote and news.
VYGR ownership FAQ
Who owns the most Voyager Therapeutics stock?
The largest shareholders of Voyager Therapeutics are BlackRock Inc (8.39%), Millennium Management LLC (7.21%), Armistice Capital, LLC (5.58%), Vestal Point Capital LP (4.26%), Vanguard Capital Management, LLC (3.81%).
What percentage of Voyager Therapeutics is owned by institutions?
Institutions hold 57.9% of Voyager Therapeutics's shares outstanding; insiders hold 14.84%.
Which funds own Voyager Therapeutics?
The largest fund holders of Voyager Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.71%), iShares Russell 2000 ETF (2.24%), Fidelity Small Cap Index (0.93%), iShares Russell 2000 Value ETF (0.80%), Vanguard Explorer Inv (0.74%).
What is Voyager Therapeutics's short interest?
4.0M shares of Voyager Therapeutics were sold short, 7.55% of the float; at the average daily volume it would take 7.57 days to cover.
Are insiders buying or selling Voyager Therapeutics?
Of the latest 9 reported insider transactions in Voyager Therapeutics (since October 3, 2025), 0 were purchases and 9 were sales.
How many shares of Voyager Therapeutics are outstanding?
Voyager Therapeutics has 61.6M shares outstanding, of which 44.5M are in the public float.